Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Active not recruiting × Fever × Clear all

Phase

Status

Completed 4 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 151 Carcinoma, Non-Small-Cell Lung 121 Multiple Myeloma 102 Prostatic Neoplasms 100 Leukemia, Myeloid, Acute 63 Neoplasms 61 Melanoma 60 Colorectal Neoplasms 60 Squamous Cell Carcinoma of Head and Neck 56 Neoplasm Metastasis 54 Lymphoma 52 Pancreatic Neoplasms 51 Lung Neoplasms 47 Ovarian Neoplasms 43 Sarcoma 37 Recurrence 37 Triple Negative Breast Neoplasms 36 Head and Neck Neoplasms 36 Leukemia, Lymphocytic, Chronic, B-Cell 35 Glioblastoma 35 Precursor Cell Lymphoblastic Leukemia-Lymphoma 34 Lymphoma, Large B-Cell, Diffuse 34 Urinary Bladder Neoplasms 33 Myelodysplastic Syndromes 32 Carcinoma, Renal Cell 32 Lymphoma, Non-Hodgkin 31 Hematologic Neoplasms 31 Brain Neoplasms 29 Stomach Neoplasms 27 Endometrial Neoplasms 27

Interventions

trametinib 1 dabrafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01972347 2025-12-16

Neo Combi

Melanoma Institute Australia

Phase 2 Active not recruiting

Fever, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡